About
Male
Peter Chambré has extensive experience in the pharmaceutical industry and significant board experience, having held a number of senior and non-executive positions in healthcare companies, including as chief executive officer of Cambridge Antibody Technology Group plc (until its acquisition by AstraZeneca PLC in 2006), chairman of ApaTech Limited and non-executive director of BTG plc. Prior to that he was chief operating officer of Celera Genomics Group and chief executive of Bespak plc. Chairman of 7TM Pharma A/S, Immatics Biotechnologies GmbH and Cancer Research Technology Ltd. Director of OneMed Sverige AB and Imperial Innovations Group plc. Trustee of Cancer Research UK.
Experience
Imperial Innovations
View →Member of the Board of Directors
31London, England, United KingdomFinance · Financial Services
Bain & Company
View →Team Member
Acquired15kArtificial Intelligence (AI) · Consulting
- Chairman of the Board of Directors · immatics biotechnologies2012 – present
- Chairman of the Board of Directors · Cancer Research Horizons2011 – present
- Member of the Board of Directors · Spectris2006 – present
- Chairman of the Board of Directors · 7TM Pharma
- Member of the Board of Trustees · Cancer Research UK
- Member of the Board of Directors · OneMed
People at Imperial Innovations
Data from: crunchbase
